American Oncology Network Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	1,744	1,266	1,138	938.24	714.68
Other Revenue	15.51	13.47	11.74	5.51	10.07
Revenue	1,759	1,279	1,150	943.75	724.74
Revenue Growth (YoY)	37.55%	11.27%	21.82%	30.22%	126.56%
Cost of Revenue	1,639	1,194	1,052	863.47	651.79
Gross Profit	120.48	85.51	98.1	80.28	72.95
Selling, General & Admin	136.57	103.43	89.25	79.37	50.88
Operating Expenses	136.57	103.43	89.25	79.37	50.88
Operating Income	-16.09	-17.92	8.84	0.91	22.07
Interest Expense	-7.06	-6.42	-3.42	-1.42	-1.12
Interest & Investment Income	3.2	1.33	0.15	0.13	0.03
Earnings From Equity Investments	0.15	-0.26	-	-	-
Other Non Operating Income (Expenses)	-3.84	-8.26	0.29	0.74	0.18
EBT Excluding Unusual Items	-23.64	-31.53	5.87	0.36	21.17
Merger & Restructuring Charges	-1.34	-31.24	-3.28	-	-
Other Unusual Items	0.51	27.08	-2.59	0.11	-
Pretax Income	-24.46	-35.69	-	0.46	21.17
Income Tax Expense	2.5	0.38	-	0.46	-0.78
Earnings From Continuing Operations	-26.96	-36.07	-	-	21.95
Minority Interest in Earnings	22.99	30.53	-	-	-
Net Income	-3.97	-5.54	-	-	21.95
Preferred Dividends & Other Adjustments	5.55	3.58	-	-	2.52
Net Income to Common	-9.52	-9.12	-	-	19.43
Net Income Growth	-	-	-	-	691.60%
Shares Outstanding (Basic)	14	7	-	-	-
Shares Outstanding (Diluted)	38	7	-	-	-
Shares Change (YoY)	460.99%	-	-	-	-
EPS (Basic)	-0.69	-1.36	-	-	-
EPS (Diluted)	-0.89	-1.36	-	-	-
Free Cash Flow	-25.9	-30.4	-13.98	-34.66	25.02
Free Cash Flow Per Share	-0.69	-4.55	-	-	-
Gross Margin	6.85%	6.69%	8.53%	8.51%	10.07%
Operating Margin	-0.92%	-1.40%	0.77%	0.10%	3.04%
Profit Margin	-0.54%	-0.71%	-	-	2.68%
Free Cash Flow Margin	-1.47%	-2.38%	-1.22%	-3.67%	3.45%
EBITDA	-5.58	-9.47	15.56	6.99	25.73
EBITDA Margin	-0.32%	-0.74%	1.35%	0.74%	3.55%
D&A For EBITDA	10.52	8.45	6.72	6.08	3.66
EBIT	-16.09	-17.92	8.84	0.91	22.07
EBIT Margin	-0.91%	-1.40%	0.77%	0.10%	3.04%
Effective Tax Rate	-	-	-	100.00%	-
Revenue as Reported	1,759	1,279	1,150	943.75	724.74

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.